Improving patient outcomes following glaucoma surgery: state of the art and future perspectives

References

• BurrJAzuara-BlancoAAvenellAMedical versus surgical interventions for open angle glaucomaCochrane Database Syst Rev20052CD00439915846712
   PubMedGoogle Scholar
• HitchingsRInitial treatment for open-angle glaucoma – medical, laser, or surgical? Surgery is the treatment of choice for open-angle glaucomaArch Ophthalmol199811622412429488281
   PubMedGoogle Scholar
• AddicksEMQuigleyHAGreenWRRobinALHistologic characteristics of filtering blebs in glaucomatous eyesArch Ophthalmol198310157957986847472
   PubMedGoogle Scholar
• LamaPJFechtnerRDAntifibrotics and wound healing in glaucoma surgerySurv Ophthalmol200348331434612745005
   PubMed Web of Science ®Google Scholar
• GeorgoulasSDahlmann-NoorABrocchiniSKhawPTModulation of wound healing during and after glaucoma surgeryProg Brain Res200817323725418929113
   PubMed Web of Science ®Google Scholar
• SkutaGLParrishRK2ndWound healing in glaucoma filtering surgerySurv Ophthalmol19873231491703328315
   PubMed Web of Science ®Google Scholar
• MillerMHJosephNHEnnisKWGriersonIHitchingsRAAn animal model of filtration surgeryTrans Ophthalmol Soc U K1985104Pt 88938973868883
   PubMedGoogle Scholar
• SchultzGCheginiNGrantMKhawPMacKaySEffects of growth factors on corneal wound healingActa Ophthalmol Suppl199220260661322013
   PubMedGoogle Scholar
• WongJWangNMillerJWSchumanJSModulation of human fibroblast activity by selected angiogenesis inhibitorsExp Eye Res19945844394517523160
   PubMed Web of Science ®Google Scholar
• TripathiRCParapuramSKTripathiBJZhongYChalamKVCorticosteroids and glaucoma riskDrugs Aging199915643945010641955
   PubMed Web of Science ®Google Scholar
• ClarkAFWordingerRJThe role of steroids in outflow resistanceExp Eye Res200988475275918977348
   PubMed Web of Science ®Google Scholar
• JohnsonDHMatsumotoYSchlemm’s canal becomes smaller after successful filtration surgeryArch Ophthalmol200011891251125610980771
   PubMedGoogle Scholar
• Lutjen-DrecollEBaranyEHFunctional and electron microscopic changes in the trabecular meshwork remaining after trabeculectomy in cynomolgus monkeysInvest Ophthalmol19741375115244209932
   PubMedGoogle Scholar
• ThomasRJayJLRaised intraocular pressure with topical steroids after trabeculectomyGraefes Arch Clin Exp Ophthalmol198822643373403169586
   PubMed Web of Science ®Google Scholar
• AraujoSVSpaethGLRothSMStaritaRJA ten-year follow-up on a prospective, randomized trial of postoperative corticosteroids after trabeculectomyOphthalmology199510212175317599098274
   PubMed Web of Science ®Google Scholar
• MueckeJBrianGSteroid-induced ocular hypertension in the presence of a functioning Molteno setonAust N Z J Ophthalmol199523167687619460
   PubMedGoogle Scholar
• ChangMRChengQLeeDABasic science and clinical aspects of wound healing in glaucoma filtering surgeryJ Ocul Pharmacol Ther199814175959493785
   PubMed Web of Science ®Google Scholar
• SkutaGLBeesonCCHigginbothamEJIntraoperative mitomycin versus postoperative 5-fluorouracil in high-risk glaucoma filtering surgeryOphthalmology19929934384441565457
   PubMed Web of Science ®Google Scholar
• KhawPTSherwoodMBMacKaySLRossiMJSchultzGFive- minute treatments with fluorouracil, floxuridine, and mitomycin have long-term effects on human Tenon’s capsule fibroblastsArch Ophthalmol19921108115011541386726
   PubMedGoogle Scholar
• GresselMGParrishRK2ndFolbergR5-fluorouracil and glaucoma filtering surgery: I. An animal modelOphthalmology19849143783836717922
   PubMed Web of Science ®Google Scholar
• ShapiroMSThoftRAFriendJParrishRKGresselMG5- Fluorouracil toxicity to the ocular surface epitheliumInvest Ophthalmol Vis Sci19852645805833980172
   PubMed Web of Science ®Google Scholar
• SmithSD’AmorePADreyerEBComparative toxicity of mitomycin C and 5-fluorouracil in vitroAm J Ophthalmol199411833323378085590
   PubMed Web of Science ®Google Scholar
• MegevandGSSalmonJFScholtzRPMurrayADThe effect of reducing the exposure time of mitomycin C in glaucoma filtering surgeryOphthalmology1995102184907831047
   PubMed Web of Science ®Google Scholar
• SchnyderCCBernasconiOMermoudAFaggioniR2,5 oder 5minütige Applikation von Mitomycin C bei fistulisierenden Operationen? Eine Vergleichstudie [Comparative study of administration time of mitomycin C in trabeculectomy: 2.5 or 5 minutes?]Klin Monbl Augenheilkd19952065307311 German7609372
   PubMed Web of Science ®Google Scholar
• ThorntonIXuMKruegerRRComparison of standard (0.02%) and low dose (0.002%) mitomycin C in the prevention of corneal haze following surface ablation for myopiaJ Refract Surg2008241S68S7618269154
   PubMed Web of Science ®Google Scholar
• MatlachJPanidouEGrehnFKlinkTLarge-area versus small-area application of mitomycin C during trabeculectomyEur J Ophthalmol201323567067723640510
   PubMed Web of Science ®Google Scholar
• OnolMAktasZHasanreisogluBEnhancement of the success rate in trabeculectomy: large-area mitomycin-C applicationClin Experiment Ophthalmol200836431632218700917
   PubMed Web of Science ®Google Scholar
• KhawPTChangLWongTTMeadADanielsJTCordeiroMFModulation of wound healing after glaucoma surgeryCurr Opin Ophthalmol200112214314811224722
   PubMed Web of Science ®Google Scholar
• CordeiroMFConstablePHAlexanderRABhattacharyaSSKhawPTEffect of varying the mitomycin-C treatment area in glaucoma filtration surgery in the rabbitInvest Ophthalmol Vis Sci1997388163916469224294
   PubMed Web of Science ®Google Scholar
• KhawPTDoyleJWSherwoodMBGriersonISchultzGMcGorraySProlonged localized tissue effects from 5-minute exposures to fluorouracil and mitomycin CArch Ophthalmol199311122632678431167
   PubMedGoogle Scholar
• KhawPTSherwoodMBDoyleJWIntraoperative and post-operative treatment with 5-fluorouracil and mitomycin-C: long term effects in vivo on subconjunctival and scleral fibroblastsInt Ophthalmol1992164–53813851428576
   PubMed Web of Science ®Google Scholar
• SeongGJParkCKimCYMitomycin-C induces the apoptosis of human Tenon’s capsule fibroblast by activation of c-Jun N-terminal kinase 1 and caspase-3 proteaseInvest Ophthalmol Vis Sci200546103545355216186332
   PubMed Web of Science ®Google Scholar
• SoltauJBRothmanRFBudenzDLRisk factors for glaucoma filtering bleb infectionsArch Ophthalmol2000118333834210721955
   PubMedGoogle Scholar
• SistoDVetrugnoMTrabuccoTCantatoreFRuggeriGSborgiaCThe role of antimetabolites in filtration surgery for neovascular glaucoma: intermediate-term follow-upActa Ophthalmol Scand200785326727117488455
   PubMedGoogle Scholar
• GreenfieldDSLiebmannJMJeeJRitchRLate-onset bleb leaks after glaucoma filtering surgeryArch Ophthalmol199811644434479565040
   PubMedGoogle Scholar
• HigginbothamEJStevensRKMuschDCBleb-related endophthalmitis after trabeculectomy with mitomycin COphthalmology199610346506568618766
   PubMed Web of Science ®Google Scholar
• KaralekasDHARosenbergLRudermanJKrupinTEffects of human glaucomatous and non-glaucomatous aqueous humor on fibroblast proliferation in vitroInvest Ophthalmol Vis Sci19943541898
   Web of Science ®Google Scholar
• TripathiRCLiJChanWFTripathiBJAqueous humor in glaucomatous eyes contains an increased level of TGF-beta 2Exp Eye Res19945967237277698265
   PubMed Web of Science ®Google Scholar
• CordeiroMFBhattacharyaSSSchultzGSKhawPTTGF-beta1, -beta2, and -beta3 in vitro: biphasic effects on Tenon’s fibroblast contraction, proliferation, and migrationInvest Ophthalmol Vis Sci200041375676310711691
   PubMed Web of Science ®Google Scholar
• CordeiroMFGayJAKhawPTHuman anti-transforming growth factor-beta2 antibody: a new glaucoma anti-scarring agentInvest Ophthalmol Vis Sci199940102225223410476787
   PubMed Web of Science ®Google Scholar
• KhawPGrehnFHolloGA phase III study of subconjunctival human anti-transforming growth factor beta(2) monoclonal antibody (CAT-152) to prevent scarring after first-time trabeculectomyOphthalmology2007114101822183017908591
   PubMed Web of Science ®Google Scholar
• GrisantiSSzurmanPWargaMDecorin modulates wound healing in experimental glaucoma filtration surgery: a pilot studyInvest Ophthalmol Vis Sci200546119119615623773
   PubMed Web of Science ®Google Scholar
• MietzHKrieglsteinGKSuramin to enhance glaucoma filtering procedures: a clinical comparison with mitomycinOphthalmic Surg Lasers200132535836911563779
   PubMedGoogle Scholar
• MietzHChevez-BarriosPFeldmanRMLiebermanMWSuramin inhibits wound healing following filtering procedures for glaucomaBr J Ophthalmol19988278168209924379
   PubMed Web of Science ®Google Scholar
• SpitzerMSSatMSchrammCBiocompatibility and antifibrotic effect of UV-cross-linked hyaluronate as a release-system for tranilast after trabeculectomy in a rabbit model – a pilot studyCurr Eye Res201237646347022577763
   PubMed Web of Science ®Google Scholar
• OshimaTKurosakaDKatoKTranilast inhibits cell proliferation and collagen synthesis by rabbit corneal and Tenon’s capsule fibroblastsCurr Eye Res200020428328610806442
   PubMed Web of Science ®Google Scholar
• ChiharaEDongJOchiaiHHamadaSEffects of tranilast on filtering blebs: a pilot studyJ Glaucoma200211212713311912360
   PubMed Web of Science ®Google Scholar
• Meyer-Ter-VehnTKatzenbergerBHanHGrehnFSchlunckGLovastatin inhibits TGF-beta-induced myofibroblast transdifferentiation in human Tenon fibroblastsInvest Ophthalmol Vis Sci20084993955396018421080
   PubMed Web of Science ®Google Scholar
• XiaoYQLiuKShenJFXuGTYeWSB-431542 inhibition of scar formation after filtration surgery and its potential mechanismInvest Ophthalmol Vis Sci20095041698170619098325
   PubMed Web of Science ®Google Scholar
• SapitroJDunmireJJScottSESuppression of transforming growth factor-beta effects in rabbit subconjunctival fibroblasts by activin receptor-like kinase 5 inhibitorMol Vis2010161880189221031133
   PubMed Web of Science ®Google Scholar
• LiNCuiJDuanXChenHFanFSuppression of type I collagen expression by miR-29b via PI3K, Akt, and Sp1 pathway in human Tenon’s fibroblastsInvest Ophthalmol Vis Sci20125331670167822297492
   PubMed Web of Science ®Google Scholar
• BaoPKodraATomic-CanicMGolinkoMSEhrlichHPBremHThe role of vascular endothelial growth factor in wound healingJ Surg Res2009153234735819027922
   PubMed Web of Science ®Google Scholar
• LiZVan BergenTVan de VeireSInhibition of vascular endothelial growth factor reduces scar formation after glaucoma filtration surgeryInvest Ophthalmol Vis Sci200950115217522519474408
   PubMed Web of Science ®Google Scholar
• HuDNRitchRLiebmannJLiuYChengBHuMSVascular endothelial growth factor is increased in aqueous humor of glaucomatous eyesJ Glaucoma200211540641012362079
   PubMed Web of Science ®Google Scholar
• TripathiRCLiJTripathiBJChalamKVAdamisAPIncreased level of vascular endothelial growth factor in aqueous humor of patients with neovascular glaucomaOphthalmology199810522322379479280
   PubMed Web of Science ®Google Scholar
• BeddyDWatsonRWFitzpatrickJMO’ConnellPRIncreased vascular endothelial growth factor production in fibroblasts isolated from strictures in patients with Crohn’s diseaseBr J Surg2004911727714716797
   PubMed Web of Science ®Google Scholar
• NissenNNPolveriniPJKochAEVolinMVGamelliRLDiPietroLAVascular endothelial growth factor mediates angiogenic activity during the proliferative phase of wound healingAm J Pathol19981526144514529626049
   PubMed Web of Science ®Google Scholar
• WilgusTAFerreiraAMOberyszynTMBergdallVKDipietroLARegulation of scar formation by vascular endothelial growth factorLab Invest200888657959018427552
   PubMed Web of Science ®Google Scholar
• MemarzadehFVarmaRLinLTPostoperative use of bevacizumab as an antifibrotic agent in glaucoma filtration surgery in the rabbitInvest Ophthalmol Vis Sci20095073233323719182254
   PubMed Web of Science ®Google Scholar
• HowAChuaJLCharltonACombined treatment with bevacizumab and 5-fluorouracil attenuates the postoperative scarring response after experimental glaucoma filtration surgeryInvest Ophthalmol Vis Sci201051292893219797222
   PubMed Web of Science ®Google Scholar
• Van BergenTVandewalleEVan de VeireSThe role of different VEGF isoforms in scar formation after glaucoma filtration surgeryExp Eye Res201193568969921907194
   PubMed Web of Science ®Google Scholar
• KahookMYSchumanJSNoeckerRJNeedle bleb revision of encapsulated filtering bleb with bevacizumabOphthalmic Surg Lasers Imaging200637214815016583638
   PubMedGoogle Scholar
• CooteMARuddleJBQinQCrowstonJGVascular changes after intra-bleb injection of bevacizumabJ Glaucoma200817751751818854726
   PubMed Web of Science ®Google Scholar
• ZarnowskiTTulidowicz-BielakMTopical bevacizumab is efficacious in the early bleb failure after trabeculectomyActa Ophthalmol2011897e605e60619925517
   PubMed Web of Science ®Google Scholar
• BiteliLGPrataTSSubconjunctival bevacizumab as an adjuvant in first-time filtration surgery for patients with primary glaucomasInt Ophthalmol201333674174623389840
   PubMed Web of Science ®Google Scholar
• Klos-RolaJTulidowicz-BielakMZarnowskiTEffects of topical bevacizumab application on early bleb failure after trabeculectomy: observational case seriesClin Ophthalmol201371929193524109173
   PubMedGoogle Scholar
• AkkanJUCilsimSRole of subconjunctival bevacizumab as an adjuvant to primary trabeculectomy: a prospective randomized comparative 1-year follow-up studyJ Glaucoma582013 Epub ahead of print
   Web of Science ®Google Scholar
• GrewalDSJainRKumarHGrewalSPEvaluation of subconjunctival bevacizumab as an adjunct to trabeculectomy a pilot studyOphthalmology20081151221412145.e214218692246
   PubMed Web of Science ®Google Scholar
• NilforushanNYadgariMKishSKNassiriNSubconjunctival bevacizumab versus mitomycin C adjunctive to trabeculectomyAm J Ophthalmol20121532352357.e35121982106
   PubMed Web of Science ®Google Scholar
• SenguptaSVenkateshRRavindranRDSafety and efficacy of using off-label bevacizumab versus mitomycin C to prevent bleb failure in a single-site phacotrabeculectomy by a randomized controlled clinical trialJ Glaucoma201221745045921543993
   PubMed Web of Science ®Google Scholar
• SedghipourMRMostafaeiATaghaviYLow-dose subconjunctival bevacizumab to augment trabeculectomy for glaucomaClin Ophthalmol2011579780021750613
   PubMedGoogle Scholar
• ChuaBENguyenDQQinQBleb vascularity following post-trabeculectomy subconjunctival bevacizumab: a pilot studyClin Experiment Ophthalmol201240877377922429268
   PubMed Web of Science ®Google Scholar
• Jurkowska-DudzinskaJKosior-JareckaEZarnowskiTComparison of the use of 5-fluorouracil and bevacizumab in primary trabeculectomy: results at 1 yearClin Experiment Ophthalmol2012404e135e14221668792
   PubMed Web of Science ®Google Scholar
• SuhWKeeCThe effect of bevacizumab on the outcome of trabeculectomy with 5-fluorouracilJ Ocul Pharmacol Ther201329764665123621628
   PubMed Web of Science ®Google Scholar
• VandewalleEAbegao PintoLVan BergenTIntracameral bevacizumab as an adjunct to trabeculectomy: a 1-year prospective, randomised studyBr J Ophthalmol2014981737824158846
   PubMed Web of Science ®Google Scholar
• Van BergenTJonckxBHollandersKInhibition of placental growth factor improves surgical outcome of glaucoma surgeryJ Cell Mol Med201317121632164324118824
   PubMed Web of Science ®Google Scholar
• InoueTKawajiTInataniMKamedaTYoshimuraNTaniharaHSimultaneous increases in multiple proinflammatory cytokines in the aqueous humor in pseudophakic glaucomatous eyesJ Cataract Refract Surg20123881389139722814044
   PubMed Web of Science ®Google Scholar
• TakaiYTanitoMOhiraAMultiplex cytokine analysis of aqueous humor in eyes with primary open-angle glaucoma, exfoliation glaucoma, and cataractInvest Ophthalmol Vis Sci201253124124722159018
   PubMed Web of Science ®Google Scholar
• KuchteyJRezaeiKAJaru-AmpornpanPSternbergPJrKuchteyRWMultiplex cytokine analysis reveals elevated concentration of interleukin-8 in glaucomatous aqueous humorInvest Ophthalmol Vis Sci201051126441644720592224
   PubMed Web of Science ®Google Scholar
• Schlotzer-SchrehardtULommatzschJKuchleMKonstasAGNaumannGOMatrix metalloproteinases and their inhibitors in aqueous humor of patients with pseudoexfoliation syndrome/glaucoma and primary open-angle glaucomaInvest Ophthalmol Vis Sci20034431117112512601038
   PubMed Web of Science ®Google Scholar
• KnorrMVolkerMDenkPOWunderlichKThielHJProliferative response of cultured human Tenon’s capsule fibroblasts to platelet-derived growth factor isoformsGraefes Arch Clin Exp Ophthalmol1997235106676719349953
   PubMed Web of Science ®Google Scholar
• CunliffeIARichardsonPSReesRCRennieIGEffect of TNF, IL-1, and IL-6 on the proliferation of human Tenon’s capsule fibroblasts in tissue cultureBr J Ophthalmol19957965905957626577
   PubMed Web of Science ®Google Scholar
• Salas-PratoMAssalianAMehdiAZDuperreJThompsonPBrazeauPInhibition by rapamycin of PDGF- and bFGF-induced human tenon fibroblast proliferation in vitroJ Glaucoma19965154598795734
   PubMed Web of Science ®Google Scholar
• WongTTMeadALKhawPTMatrix metalloproteinase inhibition modulates postoperative scarring after experimental glaucoma filtration surgeryInvest Ophthalmol Vis Sci20034431097110312601035
   PubMed Web of Science ®Google Scholar
• Martin-MartinBTovellVDahlmann-NoorAHKhawPTBaillyMThe effect of MMP inhibitor GM6001 on early fibroblast-mediated collagen matrix contraction is correlated to a decrease in cell protrusive activityEur J Cell Biol2011901263621040999
   PubMed Web of Science ®Google Scholar
• Rodriguez-AgirretxeIGarciaISoriaJAceraASuarez-CortesTMPrognosis of glaucoma surgery failure by customized gene expression PCR-arrayInvest Ophthalmol Vis Sci201253 ARVO E-Abstract 2514
   Google Scholar
• LiaoJKSetoMNomaKRho kinase (ROCK) inhibitorsJ Cardiovasc Pharmacol2007501172417666911
   PubMed Web of Science ®Google Scholar
• DoeCBentleyRBehmDJNovel Rho kinase inhibitors with anti-inflammatory and vasodilatory activitiesJ Pharmacol Exp Ther20073201899817018693
   PubMed Web of Science ®Google Scholar
• HeYXuHLiangLAntiinflammatory effect of Rho kinase blockade via inhibition of NF-kappaB activation in rheumatoid arthritisArthritis Rheum200858113366337618975348
   PubMed Web of Science ®Google Scholar
• OkamotoHYoshioTKanekoHYamanakaHInhibition of NF-kappaB signaling by fasudil as a potential therapeutic strategy for rheumatoid arthritisArthritis Rheum2010621829220039418
   PubMed Web of Science ®Google Scholar
• ZhaoLXuGZhouJThe effect of RhoA on human umbilical vein endothelial cell migration and angiogenesis in vitroOncol Rep20061551147115216596177
   PubMed Web of Science ®Google Scholar
• van Nieuw AmerongenGPKoolwijkPVersteilenAvan HinsberghVWInvolvement of RhoA/Rho kinase signaling in VEGF-induced endothelial cell migration and angiogenesis in vitroArterioscler Thromb Vasc Biol200323221121712588761
   PubMed Web of Science ®Google Scholar
• HonjoMTaniharaHKamedaTKawajiTYoshimuraNAraieMPotential role of Rho-associated protein kinase inhibitor Y-27632 in glaucoma filtration surgeryInvest Ophthalmol Vis Sci200748125549555718055804
   PubMed Web of Science ®Google Scholar
• Meyer-ter-VehnTSieprathSKatzenbergerBGebhardtSGrehnFSchlunckGContractility as a prerequisite for TGF-beta-induced myofibroblast transdifferentiation in human Tenon fibroblastsInvest Ophthalmol Vis Sci200647114895490417065504
   PubMed Web of Science ®Google Scholar
• NomotoHShiragaFKunoNPharmacokinetics of bevacizumab after topical, subconjunctival, and intravitreal administration in rabbitsInvest Ophthalmol Vis Sci200950104807481319324856
   PubMed Web of Science ®Google Scholar
• AmbatiJGragoudasESMillerJWTransscleral delivery of bioactive protein to the choroid and retinaInvest Ophthalmol Vis Sci20004151186119110752959
   PubMed Web of Science ®Google Scholar
• OzgonulCMumcuogluTGunalAThe effect of bevacizumab on wound healing modulation in an experimental trabeculectomy modelCurr Eye Res11112013 Epub ahead of print
   Web of Science ®Google Scholar
• AnandNBongCDeep sclerectomy with bevacizumab and mitomycin C: a comparative studyJ Glaucoma2192013 Epub ahead of print
   Web of Science ®Google Scholar
• KahookMYBleb morphology and vascularity after trabeculectomy with intravitreal ranibizumab: a pilot studyAm J Ophthalmol20101503399403.e39120570237
   PubMed Web of Science ®Google Scholar
• FreibergFJMatlachJGrehnFKarlSKlinkTPostoperative subconjunctival bevacizumab injection as an adjunct to 5-fluorouracil in the management of scarring after trabeculectomyClin Ophthalmol201371211121723814458
   PubMedGoogle Scholar
• ChenHYGeJGuoYJinCJLanYQLinMK[The inhibition effect of photodynamic on human Tenon capsule fibroblast cells]Zhonghua Yan Ke Za Zhi2003393160162 Chinese12880573
   PubMedGoogle Scholar
• JordanJFDiestelhorstMGrisantiSKrieglsteinGKPhotodynamic modulation of wound healing in glaucoma filtration surgeryBr J Ophthalmol200387787087512812889
   PubMed Web of Science ®Google Scholar
• DiestelhorstMGrisantiSPhotodynamic therapy to control fibrosis in human glaucomatous eyes after trabeculectomy: a clinical pilot studyArch Ophthalmol2002120213013411831913
   PubMedGoogle Scholar
• SaeedAMComparative study between trabeculectomy with photodynamic therapy (BCECF-AM) and trabeculectomy with antimetabolite (MMC) in the treatment of primary open angle glaucomaClin Ophthalmol201261651166423109802
   PubMedGoogle Scholar
• MinJLukowskiZLLevineMAPrevention of ocular scarring post glaucoma filtration surgery using the inflammatory cell and platelet binding modulator saratin in a rabbit modelPLoS One201274e3562722558182
   PubMed Web of Science ®Google Scholar
• MinJLukowskiZLLevineMAComparison of single versus multiple injections of the protein saratin for prolonging bleb survival in a rabbit modelInvest Ophthalmol Vis Sci201253127625763023033390
   PubMed Web of Science ®Google Scholar
• LukowskiZLMinJBeattieARPrevention of ocular scarring after glaucoma filtering surgery using the monoclonal antibody LT1009 (sonepcizumab) in a rabbit modelJ Glaucoma201322214515121946553
   PubMed Web of Science ®Google Scholar
• SenEBalikoglu-YilmazMBozdag-PehlivanSEffect of doxycycline on postoperative scarring after trabeculectomy in an experimental rabbit modelJ Ocul Pharmacol Ther201026539940620874665
   PubMed Web of Science ®Google Scholar
• LinXYuMWuKYuanHZhongHEffects of pirfenidone on proliferation, migration, and collagen contraction of human Tenon’s fibroblasts in vitroInvest Ophthalmol Vis Sci20095083763377019264889
   PubMed Web of Science ®Google Scholar
• ZhongHSunGLinXWuKYuMEvaluation of pirfenidone as a new postoperative antiscarring agent in experimental glaucoma surgeryInvest Ophthalmol Vis Sci20115263136314221330661
   PubMed Web of Science ®Google Scholar
• ArslanSAydemirOGulerMDagliAFModulation of postoperative scarring with tacrolimus and octreotide in experimental glaucoma filtration surgeryCurr Eye Res201237322823322335810
   PubMed Web of Science ®Google Scholar
• JacobJTLacourOJBurgoyneCFSlow release of the antimetabolite 5-fluorouracil (5-FU) from modified Baerveldt glaucoma drains to prolong drain functionBiomaterials200122243329333511700805
   PubMed Web of Science ®Google Scholar
• PolakMBValamaneshFFeltOControlled delivery of 5-chlorouracil using poly (ortho esters) in filtering surgery for glaucomaInvest Ophthalmol Vis Sci20084972993300318579761
   PubMed Web of Science ®Google Scholar
• LiWChenWJLiuWLiangLZhangMCHomemade lyophilized cross linking amniotic sustained-release drug membrane with anti-scarring role after filtering surgery in rabbit eyesInt J Ophthalmol20125555556123166864
   PubMed Web of Science ®Google Scholar
• SooHooJRSeiboldLKLaingAEKahookMYBleb morphology and histology in a rabbit model of glaucoma filtration surgery using Ozurdex®) or mitomycin-CMol Vis20121871471922509101
   PubMed Web of Science ®Google Scholar
• KhaliliARayapureddiSPaulDJA novel slow release solid bevacizumab tissue tablet prevents scarring following experimental glaucoma filtration surgery (GFS)Abstract 1645 presented at the Research in Vision and Ophthalmology Annual MeetingMay 1–5, 2011Fort Lauderdale, FL, USA
   Google Scholar